Intended for healthcare professionals


In brief

BMJ 2012; 345 doi: (Published 17 July 2012) Cite this as: BMJ 2012;345:e4824

Drugs agency consults on early access to drugs in development: The UK Medicines and Healthcare Products Regulatory Agency has launched a 12 week public consultation on proposals to launch a scheme that gives patients with life threatening, chronic, or debilitating conditions early access to drugs that are still being developed, usually having completed phase III trials but sometimes having just completed phase II. Comments can be emailed to the agency at until 5 October.

Doctors need to learn about prescribing exercise: Too few …

View Full Text

Log in

Log in through your institution


* For online subscription